3 recruiting, 1 not yet recruiting, 1 withdrawn. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Recruiting 3, Not yet recruiting 1, Withdrawn 1 |
Follow Toripalimab Injection: new trials by email Literature Review of Toripalimab Injection trials Research Report on Toripalimab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Chiauranib, Toripalimab Injection, Albumin-paclitaxel Injection - Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 | Not yet recruiting | Chipscreen Biosciences, Ltd. | 558 | 2026-03-31 | 2026-03-03 |
| A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer SHR-A1811 for Injection, SHR-1316 Injection, Toripalimab Injection - PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer | Phase 3 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 400 | 2025-08-20 | 2025-12-18 |
| 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer 9MW2821, Toripalimab, Gemcitabine - Urothelial Carcinoma | Phase 3 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 460 | 2024-08-22 | 2024-09-19 |
| Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC) Tifcemalimab injection, toripalimab injection, Placebo for Tifcemalimab - Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 3 | Recruiting | Shanghai Junshi Bioscience Co., Ltd. | 756 | 2023-11-15 | 2026-07-27 |
| A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma Toripalimab Injection, Gemcitabine Hydrochloride for Injection, Cisplatin for Injection / Carboplatin Injection - Locally Advanced or Metastatic Urothelial Carcinoma | Phase 3 | Withdrawn | Shanghai Junshi Bioscience Co., Ltd. | 2022-09-06 | 2026-07-09 |
Carcinoma, Transitional Cell (2) · Small Cell Lung Carcinoma (1) · Triple Negative Breast Neoplasms (1)
Shanghai Junshi Bioscience Co., Ltd. (2) · Chipscreen Biosciences, Ltd. (1) · Mabwell (Shanghai) Bioscience Co., Ltd. (1) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)
China (5) · Georgia (1) · Netherlands (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1)